Clin2
NCT07773350Possibly a fitNot yet recruiting

Bug-repellent baby wraps to prevent malaria

Malaria (Plasmodium Falciparum)Malaria Incidence

Part of Infections clinical trials.

This study tests whether baby wraps treated with a safe insect repellent can reduce malaria in babies. If your baby is healthy and between 2 and 4 months old, this might help protect them from malaria without daily medicine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,296 people
Ages
2 months to 99 years
Study type
Interventional

Who can take part

  • Mother is at least 18 years old.
  • Mother has a working phone with a known number.
  • Mother is the parent or legal guardian of a baby who is not a twin, and the baby is 2-4 months old.
  • You must be able to get to a study clinic for scheduled visits.
  • You and your baby must be attending a 10-week immunization visit at one of the study sites.
  • Your baby must not have HIV or sickle cell disease, and you must not be allergic to the repellents used.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07548021Not yet recruiting· Phase 1
Safety study of MMV371 injection for malaria prevention

This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.

Kigali
NCT07558122Not yet recruiting· Phase 1
Testing a new malaria vaccine in healthy adults

This study tests an experimental malaria vaccine (CVD 36000) in healthy volunteers aged 18–50. Researchers will give you the vaccine and later expose you to malaria parasites in a controlled setting to see if the vaccine protects you. This helps develop a safer vaccine for people in malaria-prone countries.

Baltimore, Maryland
NCT07021430Recruiting· Early Phase 1
Preventing Malaria in Pregnancy with Focal Drug Treatment

This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.

Kasese
NCT07246525Not yet recruiting· Phase 4
Malaria prevention pills for school children

This trial tests giving school-age children a short course of medicine to prevent malaria and see if it can reduce the spread of the disease in the community. It involves taking pills at set times during the school year.

Kampala
NCT07387341Not yet recruiting
Mosquito repellent trial for children

This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.

Kisumu
NCT06232954Recruiting
Testing a mosquito-repelling device to prevent malaria in kids

This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.

Jinja

Hear when a new Malaria (Plasmodium Falciparum) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.